Exact Mass: 318.1261

Exact Mass Matches: 318.1261

Found 148 metabolites which its exact mass value is equals to given mass value 318.1261, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tebupirimfos

Phosphorothioic acid, O-(2-(1,1-dimethylethyl)-5-pyrimidinyl) O-ethyl O-(1-methylethyl) ester

C13H23N2O3PS (318.1167)


CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10232; ORIGINAL_PRECURSOR_SCAN_NO 10230 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10218; ORIGINAL_PRECURSOR_SCAN_NO 10216 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10254; ORIGINAL_PRECURSOR_SCAN_NO 10252 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10208; ORIGINAL_PRECURSOR_SCAN_NO 10207 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10252; ORIGINAL_PRECURSOR_SCAN_NO 10250 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10257; ORIGINAL_PRECURSOR_SCAN_NO 10256

   

Histidyltyrosine

(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H18N4O4 (318.1328)


Histidyltyrosine is a dipeptide composed of histidine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginyl-Tryptophan

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-(1H-indol-3-yl)propanoate

C15H18N4O4 (318.1328)


Asparaginyl-Tryptophan is a dipeptide composed of asparagine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tyrosyl-Histidine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(1H-imidazol-5-yl)propanoate

C15H18N4O4 (318.1328)


Tyrosyl-Histidine is a dipeptide composed of tyrosine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tryptophyl-Asparagine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoate

C15H18N4O4 (318.1328)


Tryptophyl-Asparagine is a dipeptide composed of tryptophan and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

fluvoxamino acid

(5E)-5-[(2-aminoethoxy)imino]-5-[4-(trifluoromethyl)phenyl]pentanoic acid

C14H17F3N2O3 (318.1191)


fluvoxamino acid is a metabolite of fluvoxamine. Fluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. (Wikipedia)

   

Coumanolignan

Coumanolignan

C21H18O3 (318.1256)


   

Acetyl triethyl citrate

Acetyl triethyl citrate

C14H22O8 (318.1315)


   
   
   

SCHEMBL14514178

SCHEMBL14514178

C14H22O8 (318.1315)


   

2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one

2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one

C14H22O8 (318.1315)


   

(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid

(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   
   

9-(2-Thienyl)-non-6-en-8-in-4-ol-3-on-isovalerat

9-(2-Thienyl)-non-6-en-8-in-4-ol-3-on-isovalerat

C18H22O3S (318.129)


   

9-(2-Thienyl)-non-6-en-8-in-5-ol-3-on-isovalerat

9-(2-Thienyl)-non-6-en-8-in-5-ol-3-on-isovalerat

C18H22O3S (318.129)


   
   
   
   
   
   
   
   
   

Gly-Trp-Gly

H-Gly-Trp-Gly-OH

C15H18N4O4 (318.1328)


   
   

8-4-Aminobiphenyl-guanine

8-4-Aminobiphenyl-guanine

C17H14N6O1 (318.1229)


   

PD-160725 isethionate salt

PD-160725 2-hydroxyethanesulfonic acid salt

C15H18N4O4 (318.1328)


   

Ala Asp Gly Gly

(3S)-3-[(2S)-2-aminopropanamido]-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid

C11H18N4O7 (318.1175)


   

Ala Gly Asp Gly

(3S)-3-{2-[(2S)-2-aminopropanamido]acetamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C11H18N4O7 (318.1175)


   

Ala Gly Gly Asp

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)butanedioic acid

C11H18N4O7 (318.1175)


   

Asp Ala Gly Gly

(3S)-3-amino-3-{[(1S)-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)ethyl]carbamoyl}propanoic acid

C11H18N4O7 (318.1175)


   

Asp Gly Ala Gly

(3S)-3-amino-3-[({[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C11H18N4O7 (318.1175)


   

Asp Gly Gly Ala

(3S)-3-amino-3-({[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]methyl}carbamoyl)propanoic acid

C11H18N4O7 (318.1175)


   

Glu Gly Gly Gly

(4S)-4-amino-4-{[({[(carboxymethyl)carbamoyl]methyl}carbamoyl)methyl]carbamoyl}butanoic acid

C11H18N4O7 (318.1175)


   

Gly Ala Asp Gly

(3S)-3-[(2S)-2-(2-aminoacetamido)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C11H18N4O7 (318.1175)


   

Gly Ala Gly Asp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}butanedioic acid

C11H18N4O7 (318.1175)


   

Gly Asp Ala Gly

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C11H18N4O7 (318.1175)


   

Gly Asp Gly Ala

(3S)-3-(2-aminoacetamido)-3-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C11H18N4O7 (318.1175)


   

Gly Glu Gly Gly

(4S)-4-(2-aminoacetamido)-4-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)butanoic acid

C11H18N4O7 (318.1175)


   

Gly Gly Ala Asp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]butanedioic acid

C11H18N4O7 (318.1175)


   

Gly Gly Asp Ala

(3S)-3-[2-(2-aminoacetamido)acetamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C11H18N4O7 (318.1175)


   

Gly Gly Glu Gly

(4S)-4-[2-(2-aminoacetamido)acetamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C11H18N4O7 (318.1175)


   

Gly Gly Gly Glu

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}pentanedioic acid

C11H18N4O7 (318.1175)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Asn-Trp

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-carbamoylpropanoic acid

C15H18N4O4 (318.1328)


   

His-tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-5-yl)propanoic acid

C15H18N4O4 (318.1328)


A dipeptide formed from L-histidine and L-tyrosine residues.

   

TRP-Asn

2-(2-amino-3-carbamoylpropanamido)-3-(1H-indol-3-yl)propanoic acid

C15H18N4O4 (318.1328)


   

Tyr-his

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H18N4O4 (318.1328)


A dipeptide formed from L-tyrosine and L-histidine residues.

   

Tritylthiourea

Tritylthiourea

C20H18N2S (318.1191)


   

3,5-Dibenzyloxybenzaldehyde

3,5-Dibenzyloxybenzaldehyde

C21H18O3 (318.1256)


   

2,5-Bis(benzyloxy)benzenecarbaldehyde

2,5-Bis(benzyloxy)benzenecarbaldehyde

C21H18O3 (318.1256)


   

1-benzyl-3-(biphenyl-4-yl)thiourea

1-benzyl-3-(biphenyl-4-yl)thiourea

C20H18N2S (318.1191)


   

10-Undecenyl 2-bromoisobutyrate

10-Undecenyl 2-bromoisobutyrate

C15H27BrO2 (318.1194)


   

N-(6-NITRO-2-OXO-2H-CHROMEN-3-YL)HEPTANAMIDE

N-(6-NITRO-2-OXO-2H-CHROMEN-3-YL)HEPTANAMIDE

C16H18N2O5 (318.1216)


   

methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate

methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate

C16H18N2O5 (318.1216)


   

DIPIVALOYL-L-TARTARIC ACID

DIPIVALOYL-L-TARTARIC ACID

C14H22O8 (318.1315)


   
   

(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID

(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID

C16H18N2O5 (318.1216)


   

2,3-bis(phenylmethoxy)benzaldehyde

2,3-bis(phenylmethoxy)benzaldehyde

C21H18O3 (318.1256)


   

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

C21H18O3 (318.1256)


   

1,10-dibromodecane-d20

1,10-dibromodecane-d20

C10Br2D20 (318.1187)


   

(Acetylmethylene)triphenylphosphorane

(Acetylmethylene)triphenylphosphorane

C21H19OP (318.1173)


   

4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid

4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid

C16H18N2O5 (318.1216)


   

N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine

N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine

C17H14N6O (318.1229)


   

3,4-dibenzyloxybenzaldehyde

3,4-dibenzyloxybenzaldehyde

C21H18O3 (318.1256)


   

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

C21H18O3 (318.1256)


   

METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE

METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE

C16H18N2O5 (318.1216)


   

2-(Triphenylphosphoranylidene)propanal

2-(Triphenylphosphoranylidene)propanal

C21H19OP (318.1173)


   

4-(1-adamantyl)-2,6-dinitrophenol

4-(1-adamantyl)-2,6-dinitrophenol

C16H18N2O5 (318.1216)


   

tetraethyl 1,1,2,2-ethanetetracarboxylate

tetraethyl 1,1,2,2-ethanetetracarboxylate

C14H22O8 (318.1315)


   

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

C21H18O3 (318.1256)


   

(2S,5R)-6-(benzyloxy)-N-formyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbohydrazide

(2S,5R)-6-(benzyloxy)-N-formyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbohydrazide

C15H18N4O4 (318.1328)


   

(-)-Dipivaloyl-L-tartaric Acid

(-)-Dipivaloyl-L-tartaric Acid

C14H22O8 (318.1315)


   

11-Bromoundecyl methacrylate

11-Bromoundecyl methacrylate

C15H27BrO2 (318.1194)


   

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

C21H18O3 (318.1256)


LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties[1].

   
   

H-Gly-Gly-Trp-OH

H-Gly-Gly-Trp-OH

C15H18N4O4 (318.1328)


   

H-Trp-gly-gly-OH

2-[[2-[[2-amino-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]acetic acid

C15H18N4O4 (318.1328)


   

L-Asparaginyl-L-tryptophan

L-Asparaginyl-L-tryptophan

C15H18N4O4 (318.1328)


   

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

C21H18O3 (318.1256)


   

2,4-Bis(benzyloxy)benzaldehyde

2,4-Bis(benzyloxy)benzaldehyde

C21H18O3 (318.1256)


   

2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine

2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine

C17H14N6O (318.1229)


   

5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C16H18N2O5 (318.1216)


   

[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone

[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone

C16H18N2O5 (318.1216)


   

H-Gly-Trp-Gly-OH

H-Gly-Trp-Gly-OH

C15H18N4O4 (318.1328)


   

Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate

Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate

C13H17F3N4O2 (318.1304)


   

2-[2-(Difluoromethoxy)anilino]-1-(2,3-dihydroindol-1-yl)ethanone

2-[2-(Difluoromethoxy)anilino]-1-(2,3-dihydroindol-1-yl)ethanone

C17H16F2N2O2 (318.118)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)

N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)

C18H21ClNO2+ (318.1261)


   

gamma-D-glutamyl-meso-diaminoheptanedioate

gamma-D-glutamyl-meso-diaminoheptanedioate

C12H20N3O7- (318.1301)


   

3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

C19H16N3O2+ (318.1242)


   

Bis(2-ethoxycarbonylethyl) succinate

Bis(2-ethoxycarbonylethyl) succinate

C14H22O8 (318.1315)


   

Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate

Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate

C14H22O8 (318.1315)


   

Tebupirimfos

O-(2-(TERT-BUTYL)PYRIMIDIN-5-YL) O-ETHYL O-ISOPROPYL PHOSPHOROTHIOATE

C13H23N2O3PS (318.1167)


   

Tryptophylasparagine

Tryptophylasparagine

C15H18N4O4 (318.1328)


   
   
   

(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

C14H22O8 (318.1315)


   

(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one

(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one

C14H22O8 (318.1315)


   

5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

C15H23ClO5 (318.1234)


   

3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl 4,5-dihydroxyocta-2,6-dienoate

3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl 4,5-dihydroxyocta-2,6-dienoate

C14H22O8 (318.1315)


   

(4r)-4-hydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

(4r)-4-hydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O8 (318.1315)


   

7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

C18H22O3S (318.129)


   

7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   

8-[(4-hydroxyphenyl)methyl]-9,10-dihydrophenanthrene-2,5-diol

8-[(4-hydroxyphenyl)methyl]-9,10-dihydrophenanthrene-2,5-diol

C21H18O3 (318.1256)


   

(3e,5r)-7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

(3e,5r)-7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(4s,6e)-3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

(4s,6e)-3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(1as,3r,4r,4ar,6s,7r,8as)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

(1as,3r,4r,4ar,6s,7r,8as)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   

4-hydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

4-hydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O8 (318.1315)


   

8-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-6-(prop-2-en-1-yl)chromen-2-one

8-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-6-(prop-2-en-1-yl)chromen-2-one

C21H18O3 (318.1256)


   

3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(5r,6r)-5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[(2s,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

(5r,6r)-5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[(2s,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

C15H23ClO5 (318.1234)